- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: ZSP1273
Total 21 results
-
Guangdong Zhongsheng Pharmaceutical Co., Ltd.Completed
-
Guangdong Raynovent Biotech Co., LtdCompleted
-
Guangdong Raynovent Biotech Co., LtdCompleted
-
Guangdong Raynovent Biotech Co., LtdCompletedPharmacokinetics | Hepatic ImpairmentChina
-
Guangdong Raynovent Biotech Co., LtdRecruiting
-
Guangdong Raynovent Biotech Co., LtdCompleted
-
Guangdong Raynovent Biotech Co., LtdCompleted
-
Guangdong Zhongsheng Pharmaceutical Co., Ltd.CompletedSolid Tumor | Idiopathic Pulmonary Fibrosis(IPF)China
-
Guangdong Raynovent Biotech Co., LtdCompleted
-
Guangdong Zhongsheng Pharmaceutical Co., Ltd.UnknownHepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Esophageal Cancer | CholangiocarcinomaChina
-
Guangdong Raynovent Biotech Co., LtdCompletedWarfarin | Drug Drug Interaction | MidazolamChina
-
Guangdong Raynovent Biotech Co., LtdRecruitingIdiopathic Pulmonary Fibrosis (IPF)China
-
Guangdong Raynovent Biotech Co., LtdCompletedDrug-drug InteractionChina
-
Astellas Pharma IncTerminatedEGFR-TKI-naïve Patients With NSCLC Harboring EGFR Activating MutationsJapan
-
Astellas Pharma Global Development, Inc.WithdrawnSubjects With NSCLC With an EGFR Activating Mutation
-
Astellas Pharma IncTerminatedNon-small Cell Lung CancerJapan, Korea, Republic of, Taiwan
-
Astellas Pharma Global Development, Inc.TerminatedNon-small Cell Lung Cancer (NSCLC) | Epidermal Growth Factor Receptor (EGFR) MutationsUnited States
-
Astellas Pharma Global Development, Inc.WithdrawnSolid Tumors | Epidermal Growth Factor Receptor (EGFR) Mutations
-
Astellas Pharma Global Development, Inc.TerminatedNon-small Cell Lung Cancer (NSCLC)United States, Australia, Belgium, Canada, Chile, France, Germany, Hungary, Italy, Japan, Korea, Republic of, Malaysia, Netherlands, Peru, Portugal, Romania, Russian Federation, Singapore, Spain, Taiwan, Thailand, Ukraine, United Kingdom
-
Astellas Pharma Global Development, Inc.CompletedNon-Small-Cell Lung Cancer (NSCLC) | Epidermal Growth Factor Receptor MutationsUnited States
-
Guangdong Raynovent Biotech Co., LtdCompletedDrug Drug InteractionChina